AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

OPKO Health Inc.

Director's Dealing Mar 30, 2024

6963_rns_2024-03-30_c1cb0697-5817-419d-a007-f2a59a5a22bb.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

3/29/24, 10:13 AM

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

(Print of Type Responses)
1. Name and Address of Reporting Person
Roger J. Medel, M.D.
2. Issuer Name and Ticker or Trading Symbol
OPKO Health, Inc. [ OPK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director
10% Owner
Last)
OPKO Health, Inc.
4400 Biscayne Blvd.
(First) (Middle) 3. Date of Earliest Transaction (Month/Day/Year)
03/28/2024
Officer (give title below)
Other (specify below)
Miami, FL 33137
(City)
(Street) 4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
(State) (Zip)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security 2. Transaction 2A. Deemed 3. Transaction 4. Securities Acquired 5. Amount of Securities Beneficially 7. Nature
(Instr. 3) Date Execution Date, if Code (A) or Disposed of (D) Owned Following Reported Ownership of Indirect
(Month/Day/Year) any (Instr. 8) (Instr. 3, 4 and 5) Transaction(s) Form: Beneficial
(Month/Day/Year) (Instr. 3 and 4) Direct (D) Ownership
or Indirect ( Instr. 4 )
(A) or (1)
Code Amount (D) Price (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)

OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
nours per response 0.5










*
+

,
-
/
0

1
2
A
3
0
4
-
5
6
0
B
7
0
8
9
4
-
:
1
;
<
=
>
4
+

?
@
E
3
7
7
1
8
b
[
T
-
1
+
?
+

,
4
6
=
>
8
-
1
=
1
=
5
0
4
>
-
1
=
3
6
0
4

C
D
0
8
-
>
;
F
1
=
G
H
3
6
:
I
4
-
8
0

1
2
0
4
-
5
6
0
0
8
9
4
-
:
=
?
J
+

3
0
K
0
L
N
+
C
D
0
8
9
-
1
=

3
6
0
M

-
2
,
4
6
=
>
8
-
1
=
0
4
@
6
=
:
B
1
L
0
;
F
1
=
G
H
3
6
:
I
0
4
@
;
<
=
>
4
+

O
@
;
3
1
;
<
N
B
1
L
0
a
;
J

















P
+
U
+

3
6
0
C
D
4
8
-
>
6
R
/
0

=
L
V
Q
9
K
R
0
4
C
D
T
-
4
6
1
=

3
6
0
1
1
2
;
F
1
=
G
H
3
6
:
I
0
4
@
7
3
0
4
-
5
6
0
;
7
0
8
9
4
-
0
>
J
8
S
9
-
4
0
L
J
@

1
4
-
>
T
1
0
L
2

;
3
@
=
>
4
+

?
M
M

6
=
L
P
@
3
6
0
C
D
T
-
4
6
1
=
,
C
D
0
4
8
-
>
6
R
/
0
3
6
0

+

,
-
/
0

6
=
L
J
K
1
9
=
O
+

E
4
-
8
0

2

W
=
L
0
4
/
:
-
=
X
3
0
4
-
5
6
0
8
9
4
-
0
>
7
0
8
9
4
-
:
<
=
>
4
+

?
6
=
L
N
@
;
<
=
>
4
+

P
@
J
K
1
9
=
1
4
-
/
0
Q
9
K
R
0
4
1
2
7
G
6
4
0
>
1
2
Y
+

Q
9
K
R
0
4

1
2
*
_
+
0
3
0
4
-
5
6
0
[
\
=
0
4
>
G
-
T
7
0
8
9
4
-
0
>
]
1
4
K

2
Z
0
=
2
-
8
6
/
:
3
0
4
-
5
6
0
[
\
=
0
L
7
0
8
9
4
-
:
`
]
1
/
\
-
=
X
3
-
4
0
8

;
3
@
^
0
T
1
4
L
1
4

<
=
L
-
4
0
8
,
4
6
=
>
8
-
1
=
;
>
@
;
<
@
;
<
=
>
4
+

N
@
;
<
=
>
4
+

N
@
*
+

Q
6
9
4
0
1
2

<
=
L
-
4
0
8
Z
0
=
2
-
8
6
/
[
\
=
0
4
>
G
-
T
;
<
=
>
4
+

N
@
@
;
3
@
;
^
-
X
1

Z
9
^
0
K
-
=
L
4
`

^
d
e
f
g
h
i
j
c

*
+
A
_
G
:
@
T
1
4

=
6
>
0
T
4
0

/
-
=
2
1
k
l

m
n
o
p
f
l
i
o
q





r
k
s
i
h
j
t
u
o
p

7
0
5
=

3
+
^
9
R
-
=
M

J
1
4
=
0
:
v
-
]
6
8
4
0
6
8
G
/
6
>

1
2
0
8
9
4
-
0
>

R
=
2
-
8
6
/
:

1


_
?
H
A
\
=
0
L

-
4
0
8
/
:

1
4
B
1
K
K
1
=

?
H
A
O

P

?
H
A
V

?
N
?

M
7
1
8
b
Y

N

-
=
L
4
0
8
/
:
+


?

M
3
x
<
2

G
0
2
1
x
x
<
=
0
-
1
4
K

-
>

2
/
0
L

R
:
K
1
4
0
G
6
=
1
6
/

K
-
>
6
0
K
0
=
>

1
4
K
-
>

7
-
X
=
6
9
4
0

1
2
^
0
T
1
4
-
=
X

E
0
4
>
1
=
w
0
4
T
1
-
=
X

T
0
4
>
1
=
M

y
z
<
=
>
4
9
8
-
1
=

N
;
R
-
1
=

2
6
8
>

1
=
-
9
0

]
L
4
6
/

B
-
K
-
=
3
6
0
@
5
+
6
/

a
-
1
6
=
>
+

{
z

O
W
+
7
B


_
6
=
L
*
P
W
+
7
B

V
O
2
;
6
@
+

w7-X=6.94012^0T14.-=XE04>1=36.0^0K-=L4^T14.=6>0T4.0/-=214068G/6>120894-.0>R=2-86/:1\=0L-408./:14-=L408./:+x<2.G0214K->2/0LR:K140.G6=104T1.-=XT04>1=Myz<=>.498-1=N;R@5+xx<=.0 -16/K->.60K0=>14K->-1=268.>1=.-90]L46/B-K-=6/a-16.=>+{z\*OW+7B\*\_ Q1.0]-/0.G481T-0>12.G->]14KM=0|oupli}~luopflij~olgojklimkiluhjklijhko

6=L*PW+7BVO2;6@+2\G-8K9>.R0K6=96/:>-X=0L+<2>T680->=92-80=.Myz<=>.498-1=U214T80L94+ j~pmluhoiljuotkjluopflitgopj~omlukpfghtuoijghktou

Talk to a Data Expert

Have a question? We'll get back to you promptly.